A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays
Authors:
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 426, 62-69
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Matrix Effect in Ligand-Binding Assay: The Importance of Evaluating Emerging TechnologiesBioanalysis, 2014
- Development of a Method That Eliminates False-Positive Results due to Nerve Growth Factor Interference in the Assessment of Fulranumab ImmunogenicityThe AAPS Journal, 2014
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsJournal of Immunological Methods, 2008
- Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISARegulatory Toxicology and Pharmacology, 2007
- An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drugJournal of Immunological Methods, 2007
- Immunogenicity Testing by Electrochemiluminescent Detection for Antibodies Directed against Therapeutic Human Monoclonal AntibodiesClinical Chemistry, 2005
- An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigenJournal of Immunological Methods, 2005
- Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsJournal of Immunological Methods, 2004
- Detection of circulating immune complexes by PEG precipitation combined with ELISAJournal of Immunological Methods, 1985